These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8052802)

  • 1. Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice.
    Shimoda K; Yoshida M; Wagai N; Takayama S; Kato M
    Toxicol Pathol; 1993; 21(6):554-61. PubMed ID: 8052802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible relationship between phototoxicity and photodegradation of sitafloxacin, a quinolone antibacterial agent, in the auricular skin of albino mice.
    Shimoda K; Ikeda T; Okawara S; Kato M
    Toxicol Sci; 2000 Aug; 56(2):290-6. PubMed ID: 10910986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
    Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation.
    Yabe K; Goto K; Jindo T; Sekiguchi M; Furuhama K
    Toxicol Lett; 2005 Jul; 157(3):203-10. PubMed ID: 15917145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antioxidants, anti-inflammatory drugs, and histamine antagonists on sparfloxacin-induced phototoxicity in mice.
    Shimoda K; Nomura M; Kato M
    Fundam Appl Toxicol; 1996 May; 31(1):133-40. PubMed ID: 8998949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice.
    Wagai N; Yoshida M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):404-5. PubMed ID: 1622441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sparfloxacin phototoxicity: potential photoaugmentation by ultraviolet A and B sources.
    Tokura Y; Iwamoto Y; Mizutani K; Takigawa M
    Arch Dermatol Res; 1996; 288(1):45-50. PubMed ID: 8750934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative grepafloxacin phototoxicity in mouse skin.
    Owen K
    J Antimicrob Chemother; 1998 Aug; 42(2):261-4. PubMed ID: 9738848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light.
    Marutani K; Matsumoto M; Otabe Y; Nagamuta M; Tanaka K; Miyoshi A; Hasegawa T; Nagano H; Matsubara S; Kamide R
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2217-23. PubMed ID: 8257147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic photoreceptor cell death induced by quinolone phototoxicity in mice.
    Shimoda K; Kato M
    Toxicol Lett; 1999 Mar; 105(1):9-15. PubMed ID: 10092051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of quinolone phototoxicity.
    Shimoda K
    Toxicol Lett; 1998 Dec; 102-103():369-73. PubMed ID: 10022281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents.
    Umezawa N; Arakane K; Ryu A; Mashiko S; Hirobe M; Nagano T
    Arch Biochem Biophys; 1997 Jun; 342(2):275-81. PubMed ID: 9186488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LD50 value, phototoxicity and convulsion induction test of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acid hemihydrate in laboratory animals.
    Shimoda K; Akahane K; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jun; 46(6):625-8. PubMed ID: 8767355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the phototoxic potential of trovafloxacin in BALB/c mice.
    Mayne JT; Johnson NJ; Kluwe WM; Lencoski DL; Polzer RJ
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():67-73. PubMed ID: 9222073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototoxic potential of quinolone antibacterial agents in Balb/c mice.
    Wagai N; Yamaguchi F; Sekiguchi M; Tawara K
    Toxicol Lett; 1990 Dec; 54(2-3):299-308. PubMed ID: 2260126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phototoxic retinal degeneration and toxicokinetics of sitafloxacin, a quinolone antibacterial agent, in mice.
    Shimoda K; Okawara S; Kato M
    Arch Toxicol; 2001 Sep; 75(7):395-9. PubMed ID: 11693179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity.
    Dawe RS; Ibbotson SH; Sanderson JB; Thomson EM; Ferguson J
    Br J Dermatol; 2003 Dec; 149(6):1232-41. PubMed ID: 14674902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of prostaglandin production by quinolone phototoxicity in Balb/c 3T3 mouse fibroblast cells in vitro.
    Shimoda K; Wagai N; Kato M
    Fundam Appl Toxicol; 1997 Apr; 36(2):157-62. PubMed ID: 9143485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
    Fujita H; Matsuo I
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):202-5. PubMed ID: 7880759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of phototoxic tests of fluoroquinolones in vitro.
    Zhang T; Li JL; Ma XC; Xin J; Tu ZH
    Acta Pharmacol Sin; 2003 May; 24(5):453-9. PubMed ID: 12740182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.